nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—lung cancer—esophageal cancer	0.346	1	CtDrD
Paclitaxel—NR1I2—esophageal cancer	0.099	0.291	CbGaD
Paclitaxel—BCL2—esophageal cancer	0.082	0.241	CbGaD
Paclitaxel—CYP1B1—esophageal cancer	0.0569	0.167	CbGaD
Paclitaxel—ABCC2—esophageal cancer	0.0444	0.13	CbGaD
Paclitaxel—CYP19A1—esophageal cancer	0.0417	0.123	CbGaD
Paclitaxel—ABCC10—Methotrexate—esophageal cancer	0.0312	0.201	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—esophageal cancer	0.0174	0.112	CbGbCtD
Paclitaxel—ABCB1—esophageal cancer	0.0163	0.048	CbGaD
Paclitaxel—ABCC2—Carboplatin—esophageal cancer	0.0161	0.103	CbGbCtD
Paclitaxel—ABCG2—Carboplatin—esophageal cancer	0.0145	0.0934	CbGbCtD
Paclitaxel—ABCC2—Cisplatin—esophageal cancer	0.0137	0.0883	CbGbCtD
Paclitaxel—ABCG2—Cisplatin—esophageal cancer	0.0124	0.0798	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—esophageal cancer	0.012	0.0774	CbGbCtD
Paclitaxel—CYP2C9—Capecitabine—esophageal cancer	0.00915	0.0589	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—esophageal cancer	0.00891	0.0573	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—esophageal cancer	0.00805	0.0518	CbGbCtD
Paclitaxel—CYP2C9—Cisplatin—esophageal cancer	0.00461	0.0297	CbGbCtD
Paclitaxel—ABCB1—Cisplatin—esophageal cancer	0.00447	0.0288	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—esophageal cancer	0.0029	0.0187	CbGbCtD
Paclitaxel—BCL2—neck—esophageal cancer	0.000926	0.039	CbGeAlD
Paclitaxel—NR1I2—digestive system—esophageal cancer	0.000806	0.034	CbGeAlD
Paclitaxel—MAP2—neck—esophageal cancer	0.000802	0.0338	CbGeAlD
Paclitaxel—Docetaxel—NR1I2—esophageal cancer	0.000707	0.266	CrCbGaD
Paclitaxel—BCL2—epithelium—esophageal cancer	0.00063	0.0265	CbGeAlD
Paclitaxel—BCL2—smooth muscle tissue—esophageal cancer	0.000607	0.0256	CbGeAlD
Paclitaxel—Docetaxel—BCL2—esophageal cancer	0.000586	0.22	CrCbGaD
Paclitaxel—MAP2—bronchus—esophageal cancer	0.000537	0.0226	CbGeAlD
Paclitaxel—TUBB3—digestive system—esophageal cancer	0.000527	0.0222	CbGeAlD
Paclitaxel—MAP4—digestive system—esophageal cancer	0.000527	0.0222	CbGeAlD
Paclitaxel—MAP2—trachea—esophageal cancer	0.000482	0.0203	CbGeAlD
Paclitaxel—BCL2—digestive system—esophageal cancer	0.000479	0.0202	CbGeAlD
Paclitaxel—MAP4—lung—esophageal cancer	0.00044	0.0186	CbGeAlD
Paclitaxel—TUBB3—lung—esophageal cancer	0.00044	0.0186	CbGeAlD
Paclitaxel—MAP2—digestive system—esophageal cancer	0.000415	0.0175	CbGeAlD
Paclitaxel—Docetaxel—CYP1B1—esophageal cancer	0.000406	0.153	CrCbGaD
Paclitaxel—TUBB2B—bronchus—esophageal cancer	0.000401	0.0169	CbGeAlD
Paclitaxel—BCL2—lung—esophageal cancer	0.0004	0.0169	CbGeAlD
Paclitaxel—ABCB11—digestive system—esophageal cancer	0.000398	0.0168	CbGeAlD
Paclitaxel—SLCO1B3—lung—esophageal cancer	0.000385	0.0162	CbGeAlD
Paclitaxel—Docetaxel—EGFR—esophageal cancer	0.000383	0.144	CrCbGaD
Paclitaxel—MAPT—lymph node—esophageal cancer	0.000383	0.0161	CbGeAlD
Paclitaxel—TUBB—bronchus—esophageal cancer	0.00038	0.016	CbGeAlD
Paclitaxel—TUBB6—epithelium—esophageal cancer	0.000378	0.0159	CbGeAlD
Paclitaxel—TUBB2A—bronchus—esophageal cancer	0.000378	0.0159	CbGeAlD
Paclitaxel—TUBB6—bronchus—esophageal cancer	0.000373	0.0157	CbGeAlD
Paclitaxel—TUBB—smooth muscle tissue—esophageal cancer	0.000372	0.0157	CbGeAlD
Paclitaxel—TUBB2A—smooth muscle tissue—esophageal cancer	0.00037	0.0156	CbGeAlD
Paclitaxel—TUBB6—smooth muscle tissue—esophageal cancer	0.000365	0.0154	CbGeAlD
Paclitaxel—TUBB2B—trachea—esophageal cancer	0.00036	0.0152	CbGeAlD
Paclitaxel—MAP2—lung—esophageal cancer	0.000347	0.0146	CbGeAlD
Paclitaxel—TUBB—trachea—esophageal cancer	0.000341	0.0144	CbGeAlD
Paclitaxel—TUBB2A—trachea—esophageal cancer	0.000339	0.0143	CbGeAlD
Paclitaxel—TUBB6—trachea—esophageal cancer	0.000335	0.0141	CbGeAlD
Paclitaxel—ABCC10—bronchus—esophageal cancer	0.000326	0.0137	CbGeAlD
Paclitaxel—TUBB4B—bronchus—esophageal cancer	0.000324	0.0136	CbGeAlD
Paclitaxel—TUBB4A—digestive system—esophageal cancer	0.000321	0.0135	CbGeAlD
Paclitaxel—TUBB4B—smooth muscle tissue—esophageal cancer	0.000317	0.0134	CbGeAlD
Paclitaxel—Docetaxel—ABCC2—esophageal cancer	0.000317	0.119	CrCbGaD
Paclitaxel—TUBB2B—digestive system—esophageal cancer	0.00031	0.0131	CbGeAlD
Paclitaxel—MAP4—lymph node—esophageal cancer	0.000301	0.0127	CbGeAlD
Paclitaxel—ABCC10—trachea—esophageal cancer	0.000293	0.0123	CbGeAlD
Paclitaxel—TUBB2A—digestive system—esophageal cancer	0.000292	0.0123	CbGeAlD
Paclitaxel—TUBB4B—trachea—esophageal cancer	0.000291	0.0123	CbGeAlD
Paclitaxel—TUBB6—digestive system—esophageal cancer	0.000288	0.0121	CbGeAlD
Paclitaxel—BCL2—lymph node—esophageal cancer	0.000274	0.0115	CbGeAlD
Paclitaxel—TUBB4A—lung—esophageal cancer	0.000268	0.0113	CbGeAlD
Paclitaxel—TUBB2B—lung—esophageal cancer	0.000259	0.0109	CbGeAlD
Paclitaxel—ABCC10—digestive system—esophageal cancer	0.000252	0.0106	CbGeAlD
Paclitaxel—CYP1B1—smooth muscle tissue—esophageal cancer	0.000251	0.0106	CbGeAlD
Paclitaxel—TUBB4B—digestive system—esophageal cancer	0.00025	0.0105	CbGeAlD
Paclitaxel—TUBB—lung—esophageal cancer	0.000245	0.0103	CbGeAlD
Paclitaxel—TUBB2A—lung—esophageal cancer	0.000244	0.0103	CbGeAlD
Paclitaxel—TUBB6—lung—esophageal cancer	0.00024	0.0101	CbGeAlD
Paclitaxel—MAP2—lymph node—esophageal cancer	0.000237	0.00999	CbGeAlD
Paclitaxel—ABCC1—bronchus—esophageal cancer	0.000231	0.00972	CbGeAlD
Paclitaxel—ABCC10—lung—esophageal cancer	0.00021	0.00887	CbGeAlD
Paclitaxel—TUBB4B—lung—esophageal cancer	0.000209	0.00881	CbGeAlD
Paclitaxel—ABCC1—trachea—esophageal cancer	0.000207	0.00873	CbGeAlD
Paclitaxel—ABCC2—digestive system—esophageal cancer	0.000202	0.00853	CbGeAlD
Paclitaxel—CYP1B1—digestive system—esophageal cancer	0.000198	0.00835	CbGeAlD
Paclitaxel—TUBB4A—lymph node—esophageal cancer	0.000183	0.00772	CbGeAlD
Paclitaxel—TUBB2B—lymph node—esophageal cancer	0.000177	0.00746	CbGeAlD
Paclitaxel—TUBB—lymph node—esophageal cancer	0.000168	0.00706	CbGeAlD
Paclitaxel—TUBB2A—lymph node—esophageal cancer	0.000167	0.00703	CbGeAlD
Paclitaxel—CYP1B1—lung—esophageal cancer	0.000166	0.00698	CbGeAlD
Paclitaxel—TUBB6—lymph node—esophageal cancer	0.000164	0.00693	CbGeAlD
Paclitaxel—ABCC1—lung—esophageal cancer	0.000149	0.00627	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—esophageal cancer	0.000144	0.0543	CrCbGaD
Paclitaxel—ABCC10—lymph node—esophageal cancer	0.000144	0.00607	CbGeAlD
Paclitaxel—TUBB4B—lymph node—esophageal cancer	0.000143	0.00602	CbGeAlD
Paclitaxel—CYP3A5—digestive system—esophageal cancer	0.000137	0.00577	CbGeAlD
Paclitaxel—CYP2C9—digestive system—esophageal cancer	0.000135	0.00568	CbGeAlD
Paclitaxel—ABCG2—lung—esophageal cancer	0.000123	0.00519	CbGeAlD
Paclitaxel—CYP19A1—lymph node—esophageal cancer	0.000121	0.0051	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—esophageal cancer	0.000117	0.0438	CrCbGaD
Paclitaxel—ABCC2—lymph node—esophageal cancer	0.000116	0.00487	CbGeAlD
Paclitaxel—CYP3A5—lung—esophageal cancer	0.000114	0.00482	CbGeAlD
Paclitaxel—CYP1B1—lymph node—esophageal cancer	0.000113	0.00477	CbGeAlD
Paclitaxel—CYP3A4—digestive system—esophageal cancer	0.000103	0.00433	CbGeAlD
Paclitaxel—ABCC1—lymph node—esophageal cancer	0.000102	0.00429	CbGeAlD
Paclitaxel—ABCB1—epithelium—esophageal cancer	9.57e-05	0.00403	CbGeAlD
Paclitaxel—ABCB1—trachea—esophageal cancer	8.46e-05	0.00356	CbGeAlD
Paclitaxel—ABCG2—lymph node—esophageal cancer	8.43e-05	0.00355	CbGeAlD
Paclitaxel—ABCB1—digestive system—esophageal cancer	7.28e-05	0.00307	CbGeAlD
Paclitaxel—Dysphagia—Capecitabine—esophageal cancer	7.16e-05	0.00104	CcSEcCtD
Paclitaxel—Thrombophlebitis—Methotrexate—esophageal cancer	7.13e-05	0.00103	CcSEcCtD
Paclitaxel—Polyuria—Methotrexate—esophageal cancer	7.03e-05	0.00102	CcSEcCtD
Paclitaxel—Immune system disorder—Cisplatin—esophageal cancer	7.03e-05	0.00102	CcSEcCtD
Paclitaxel—Mediastinal disorder—Cisplatin—esophageal cancer	7.01e-05	0.00101	CcSEcCtD
Paclitaxel—Sweating increased—Capecitabine—esophageal cancer	6.98e-05	0.00101	CcSEcCtD
Paclitaxel—Arrhythmia—Cisplatin—esophageal cancer	6.95e-05	0.00101	CcSEcCtD
Paclitaxel—Bronchitis—Capecitabine—esophageal cancer	6.89e-05	0.000997	CcSEcCtD
Paclitaxel—Alopecia—Cisplatin—esophageal cancer	6.87e-05	0.000994	CcSEcCtD
Paclitaxel—Pancytopenia—Capecitabine—esophageal cancer	6.8e-05	0.000984	CcSEcCtD
Paclitaxel—Erythema—Cisplatin—esophageal cancer	6.77e-05	0.000979	CcSEcCtD
Paclitaxel—Malnutrition—Cisplatin—esophageal cancer	6.77e-05	0.000979	CcSEcCtD
Paclitaxel—Neutropenia—Capecitabine—esophageal cancer	6.7e-05	0.000969	CcSEcCtD
Paclitaxel—Dysuria—Capecitabine—esophageal cancer	6.7e-05	0.000969	CcSEcCtD
Paclitaxel—Renal failure acute—Methotrexate—esophageal cancer	6.68e-05	0.000967	CcSEcCtD
Paclitaxel—Flatulence—Cisplatin—esophageal cancer	6.67e-05	0.000965	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Capecitabine—esophageal cancer	6.66e-05	0.000963	CcSEcCtD
Paclitaxel—Dermatitis exfoliative—Methotrexate—esophageal cancer	6.54e-05	0.000946	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Capecitabine—esophageal cancer	6.54e-05	0.000946	CcSEcCtD
Paclitaxel—Weight increased—Capecitabine—esophageal cancer	6.52e-05	0.000943	CcSEcCtD
Paclitaxel—Visual disturbance—Methotrexate—esophageal cancer	6.51e-05	0.000942	CcSEcCtD
Paclitaxel—Muscle spasms—Cisplatin—esophageal cancer	6.51e-05	0.000942	CcSEcCtD
Paclitaxel—Weight decreased—Capecitabine—esophageal cancer	6.48e-05	0.000937	CcSEcCtD
Paclitaxel—Hyperglycaemia—Capecitabine—esophageal cancer	6.46e-05	0.000935	CcSEcCtD
Paclitaxel—Pneumonia—Capecitabine—esophageal cancer	6.42e-05	0.000929	CcSEcCtD
Paclitaxel—Infestation—Capecitabine—esophageal cancer	6.39e-05	0.000924	CcSEcCtD
Paclitaxel—Infestation NOS—Capecitabine—esophageal cancer	6.39e-05	0.000924	CcSEcCtD
Paclitaxel—Vision blurred—Cisplatin—esophageal cancer	6.38e-05	0.000923	CcSEcCtD
Paclitaxel—Depression—Capecitabine—esophageal cancer	6.37e-05	0.000921	CcSEcCtD
Paclitaxel—Tremor—Cisplatin—esophageal cancer	6.34e-05	0.000918	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	6.33e-05	0.000916	CcSEcCtD
Paclitaxel—Acute coronary syndrome—Capecitabine—esophageal cancer	6.3e-05	0.000911	CcSEcCtD
Paclitaxel—Cerebrovascular accident—Methotrexate—esophageal cancer	6.3e-05	0.000911	CcSEcCtD
Paclitaxel—Lethargy—Methotrexate—esophageal cancer	6.3e-05	0.000911	CcSEcCtD
Paclitaxel—Ill-defined disorder—Cisplatin—esophageal cancer	6.28e-05	0.000909	CcSEcCtD
Paclitaxel—Renal failure—Capecitabine—esophageal cancer	6.28e-05	0.000908	CcSEcCtD
Paclitaxel—Myocardial infarction—Capecitabine—esophageal cancer	6.26e-05	0.000906	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Capecitabine—esophageal cancer	6.26e-05	0.000906	CcSEcCtD
Paclitaxel—Anaemia—Cisplatin—esophageal cancer	6.26e-05	0.000905	CcSEcCtD
Paclitaxel—Stomatitis—Capecitabine—esophageal cancer	6.23e-05	0.000901	CcSEcCtD
Paclitaxel—Conjunctivitis—Capecitabine—esophageal cancer	6.21e-05	0.000898	CcSEcCtD
Paclitaxel—Urinary tract infection—Capecitabine—esophageal cancer	6.21e-05	0.000898	CcSEcCtD
Paclitaxel—Malaise—Cisplatin—esophageal cancer	6.11e-05	0.000883	CcSEcCtD
Paclitaxel—Haematuria—Capecitabine—esophageal cancer	6.09e-05	0.000881	CcSEcCtD
Paclitaxel—ABCB1—lung—esophageal cancer	6.08e-05	0.00256	CbGeAlD
Paclitaxel—Leukopenia—Cisplatin—esophageal cancer	6.06e-05	0.000877	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Capecitabine—esophageal cancer	6.04e-05	0.000874	CcSEcCtD
Paclitaxel—Epistaxis—Capecitabine—esophageal cancer	6.02e-05	0.000871	CcSEcCtD
Paclitaxel—Convulsion—Cisplatin—esophageal cancer	5.87e-05	0.000849	CcSEcCtD
Paclitaxel—Mood swings—Methotrexate—esophageal cancer	5.84e-05	0.000845	CcSEcCtD
Paclitaxel—Bradycardia—Capecitabine—esophageal cancer	5.84e-05	0.000844	CcSEcCtD
Paclitaxel—Ataxia—Methotrexate—esophageal cancer	5.8e-05	0.000839	CcSEcCtD
Paclitaxel—Myalgia—Cisplatin—esophageal cancer	5.76e-05	0.000834	CcSEcCtD
Paclitaxel—Haemoglobin—Capecitabine—esophageal cancer	5.76e-05	0.000834	CcSEcCtD
Paclitaxel—Rhinitis—Capecitabine—esophageal cancer	5.75e-05	0.000832	CcSEcCtD
Paclitaxel—Anxiety—Cisplatin—esophageal cancer	5.74e-05	0.000831	CcSEcCtD
Paclitaxel—Haemorrhage—Capecitabine—esophageal cancer	5.73e-05	0.000829	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	5.72e-05	0.000828	CcSEcCtD
Paclitaxel—Hypoaesthesia—Capecitabine—esophageal cancer	5.7e-05	0.000825	CcSEcCtD
Paclitaxel—Liver function test abnormal—Methotrexate—esophageal cancer	5.7e-05	0.000824	CcSEcCtD
Paclitaxel—Discomfort—Cisplatin—esophageal cancer	5.7e-05	0.000824	CcSEcCtD
Paclitaxel—Pharyngitis—Capecitabine—esophageal cancer	5.69e-05	0.000823	CcSEcCtD
Paclitaxel—Urinary tract disorder—Capecitabine—esophageal cancer	5.66e-05	0.000819	CcSEcCtD
Paclitaxel—Oedema peripheral—Capecitabine—esophageal cancer	5.65e-05	0.000817	CcSEcCtD
Paclitaxel—Connective tissue disorder—Capecitabine—esophageal cancer	5.63e-05	0.000815	CcSEcCtD
Paclitaxel—Urethral disorder—Capecitabine—esophageal cancer	5.62e-05	0.000813	CcSEcCtD
Paclitaxel—Breast disorder—Methotrexate—esophageal cancer	5.58e-05	0.000807	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	5.56e-05	0.000804	CcSEcCtD
Paclitaxel—Anaphylactic shock—Cisplatin—esophageal cancer	5.53e-05	0.000799	CcSEcCtD
Paclitaxel—Oedema—Cisplatin—esophageal cancer	5.53e-05	0.000799	CcSEcCtD
Paclitaxel—Visual impairment—Capecitabine—esophageal cancer	5.53e-05	0.000799	CcSEcCtD
Paclitaxel—Infection—Cisplatin—esophageal cancer	5.49e-05	0.000794	CcSEcCtD
Paclitaxel—Erythema multiforme—Capecitabine—esophageal cancer	5.42e-05	0.000784	CcSEcCtD
Paclitaxel—Nervous system disorder—Cisplatin—esophageal cancer	5.42e-05	0.000784	CcSEcCtD
Paclitaxel—Thrombocytopenia—Cisplatin—esophageal cancer	5.41e-05	0.000783	CcSEcCtD
Paclitaxel—Tachycardia—Cisplatin—esophageal cancer	5.39e-05	0.00078	CcSEcCtD
Paclitaxel—Skin disorder—Cisplatin—esophageal cancer	5.37e-05	0.000776	CcSEcCtD
Paclitaxel—Eye disorder—Capecitabine—esophageal cancer	5.36e-05	0.000775	CcSEcCtD
Paclitaxel—Tinnitus—Capecitabine—esophageal cancer	5.35e-05	0.000773	CcSEcCtD
Paclitaxel—Hyperhidrosis—Cisplatin—esophageal cancer	5.34e-05	0.000773	CcSEcCtD
Paclitaxel—Flushing—Capecitabine—esophageal cancer	5.32e-05	0.00077	CcSEcCtD
Paclitaxel—Cardiac disorder—Capecitabine—esophageal cancer	5.32e-05	0.00077	CcSEcCtD
Paclitaxel—Anorexia—Cisplatin—esophageal cancer	5.27e-05	0.000762	CcSEcCtD
Paclitaxel—Pancreatitis—Methotrexate—esophageal cancer	5.23e-05	0.000756	CcSEcCtD
Paclitaxel—Angiopathy—Capecitabine—esophageal cancer	5.2e-05	0.000753	CcSEcCtD
Paclitaxel—Immune system disorder—Capecitabine—esophageal cancer	5.18e-05	0.000749	CcSEcCtD
Paclitaxel—Mediastinal disorder—Capecitabine—esophageal cancer	5.17e-05	0.000748	CcSEcCtD
Paclitaxel—Hypotension—Cisplatin—esophageal cancer	5.16e-05	0.000747	CcSEcCtD
Paclitaxel—Chills—Capecitabine—esophageal cancer	5.14e-05	0.000744	CcSEcCtD
Paclitaxel—Arrhythmia—Capecitabine—esophageal cancer	5.12e-05	0.000741	CcSEcCtD
Paclitaxel—Alopecia—Capecitabine—esophageal cancer	5.07e-05	0.000733	CcSEcCtD
Paclitaxel—Pancytopenia—Methotrexate—esophageal cancer	5.06e-05	0.000733	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Cisplatin—esophageal cancer	5.03e-05	0.000728	CcSEcCtD
Paclitaxel—Mental disorder—Capecitabine—esophageal cancer	5.02e-05	0.000727	CcSEcCtD
Paclitaxel—Erythema—Capecitabine—esophageal cancer	4.99e-05	0.000722	CcSEcCtD
Paclitaxel—Malnutrition—Capecitabine—esophageal cancer	4.99e-05	0.000722	CcSEcCtD
Paclitaxel—Dysuria—Methotrexate—esophageal cancer	4.99e-05	0.000721	CcSEcCtD
Paclitaxel—Neutropenia—Methotrexate—esophageal cancer	4.99e-05	0.000721	CcSEcCtD
Paclitaxel—Paraesthesia—Cisplatin—esophageal cancer	4.96e-05	0.000718	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Methotrexate—esophageal cancer	4.96e-05	0.000717	CcSEcCtD
Paclitaxel—Dyspnoea—Cisplatin—esophageal cancer	4.93e-05	0.000713	CcSEcCtD
Paclitaxel—Flatulence—Capecitabine—esophageal cancer	4.92e-05	0.000711	CcSEcCtD
Paclitaxel—Dysgeusia—Capecitabine—esophageal cancer	4.89e-05	0.000707	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Methotrexate—esophageal cancer	4.87e-05	0.000704	CcSEcCtD
Paclitaxel—Back pain—Capecitabine—esophageal cancer	4.83e-05	0.000698	CcSEcCtD
Paclitaxel—Decreased appetite—Cisplatin—esophageal cancer	4.8e-05	0.000695	CcSEcCtD
Paclitaxel—Muscle spasms—Capecitabine—esophageal cancer	4.8e-05	0.000694	CcSEcCtD
Paclitaxel—Pneumonia—Methotrexate—esophageal cancer	4.78e-05	0.000692	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Cisplatin—esophageal cancer	4.77e-05	0.00069	CcSEcCtD
Paclitaxel—Infestation—Methotrexate—esophageal cancer	4.75e-05	0.000688	CcSEcCtD
Paclitaxel—Infestation NOS—Methotrexate—esophageal cancer	4.75e-05	0.000688	CcSEcCtD
Paclitaxel—Depression—Methotrexate—esophageal cancer	4.74e-05	0.000686	CcSEcCtD
Paclitaxel—Pain—Cisplatin—esophageal cancer	4.73e-05	0.000684	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	4.71e-05	0.000682	CcSEcCtD
Paclitaxel—Vision blurred—Capecitabine—esophageal cancer	4.7e-05	0.00068	CcSEcCtD
Paclitaxel—Tremor—Capecitabine—esophageal cancer	4.68e-05	0.000676	CcSEcCtD
Paclitaxel—Renal failure—Methotrexate—esophageal cancer	4.67e-05	0.000676	CcSEcCtD
Paclitaxel—Stomatitis—Methotrexate—esophageal cancer	4.63e-05	0.00067	CcSEcCtD
Paclitaxel—Ill-defined disorder—Capecitabine—esophageal cancer	4.63e-05	0.00067	CcSEcCtD
Paclitaxel—Conjunctivitis—Methotrexate—esophageal cancer	4.62e-05	0.000669	CcSEcCtD
Paclitaxel—Anaemia—Capecitabine—esophageal cancer	4.61e-05	0.000667	CcSEcCtD
Paclitaxel—Feeling abnormal—Cisplatin—esophageal cancer	4.55e-05	0.000659	CcSEcCtD
Paclitaxel—Haematuria—Methotrexate—esophageal cancer	4.53e-05	0.000656	CcSEcCtD
Paclitaxel—Malaise—Capecitabine—esophageal cancer	4.5e-05	0.000651	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Methotrexate—esophageal cancer	4.5e-05	0.00065	CcSEcCtD
Paclitaxel—Epistaxis—Methotrexate—esophageal cancer	4.48e-05	0.000649	CcSEcCtD
Paclitaxel—Vertigo—Capecitabine—esophageal cancer	4.48e-05	0.000649	CcSEcCtD
Paclitaxel—Syncope—Capecitabine—esophageal cancer	4.48e-05	0.000647	CcSEcCtD
Paclitaxel—Leukopenia—Capecitabine—esophageal cancer	4.47e-05	0.000646	CcSEcCtD
Paclitaxel—Palpitations—Capecitabine—esophageal cancer	4.41e-05	0.000638	CcSEcCtD
Paclitaxel—Loss of consciousness—Capecitabine—esophageal cancer	4.39e-05	0.000635	CcSEcCtD
Paclitaxel—Body temperature increased—Cisplatin—esophageal cancer	4.37e-05	0.000632	CcSEcCtD
Paclitaxel—Cough—Capecitabine—esophageal cancer	4.36e-05	0.00063	CcSEcCtD
Paclitaxel—Hypertension—Capecitabine—esophageal cancer	4.31e-05	0.000623	CcSEcCtD
Paclitaxel—Haemoglobin—Methotrexate—esophageal cancer	4.29e-05	0.000621	CcSEcCtD
Paclitaxel—Haemorrhage—Methotrexate—esophageal cancer	4.27e-05	0.000617	CcSEcCtD
Paclitaxel—Myalgia—Capecitabine—esophageal cancer	4.25e-05	0.000615	CcSEcCtD
Paclitaxel—Arthralgia—Capecitabine—esophageal cancer	4.25e-05	0.000615	CcSEcCtD
Paclitaxel—Chest pain—Capecitabine—esophageal cancer	4.25e-05	0.000615	CcSEcCtD
Paclitaxel—Pharyngitis—Methotrexate—esophageal cancer	4.24e-05	0.000613	CcSEcCtD
Paclitaxel—Anxiety—Capecitabine—esophageal cancer	4.23e-05	0.000613	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	4.22e-05	0.00061	CcSEcCtD
Paclitaxel—Urinary tract disorder—Methotrexate—esophageal cancer	4.22e-05	0.00061	CcSEcCtD
Paclitaxel—Discomfort—Capecitabine—esophageal cancer	4.2e-05	0.000607	CcSEcCtD
Paclitaxel—Urethral disorder—Methotrexate—esophageal cancer	4.18e-05	0.000605	CcSEcCtD
Paclitaxel—ABCB1—lymph node—esophageal cancer	4.16e-05	0.00175	CbGeAlD
Paclitaxel—Dry mouth—Capecitabine—esophageal cancer	4.16e-05	0.000601	CcSEcCtD
Paclitaxel—Visual impairment—Methotrexate—esophageal cancer	4.11e-05	0.000595	CcSEcCtD
Paclitaxel—Confusional state—Capecitabine—esophageal cancer	4.11e-05	0.000594	CcSEcCtD
Paclitaxel—Oedema—Capecitabine—esophageal cancer	4.07e-05	0.000589	CcSEcCtD
Paclitaxel—Hypersensitivity—Cisplatin—esophageal cancer	4.07e-05	0.000589	CcSEcCtD
Paclitaxel—Infection—Capecitabine—esophageal cancer	4.05e-05	0.000585	CcSEcCtD
Paclitaxel—Erythema multiforme—Methotrexate—esophageal cancer	4.04e-05	0.000584	CcSEcCtD
Paclitaxel—Shock—Capecitabine—esophageal cancer	4.01e-05	0.00058	CcSEcCtD
Paclitaxel—Nervous system disorder—Capecitabine—esophageal cancer	3.99e-05	0.000578	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—esophageal cancer	3.99e-05	0.000577	CcSEcCtD
Paclitaxel—Thrombocytopenia—Capecitabine—esophageal cancer	3.99e-05	0.000577	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—esophageal cancer	3.98e-05	0.000576	CcSEcCtD
Paclitaxel—Tachycardia—Capecitabine—esophageal cancer	3.98e-05	0.000575	CcSEcCtD
Paclitaxel—Asthenia—Cisplatin—esophageal cancer	3.96e-05	0.000574	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—esophageal cancer	3.96e-05	0.000573	CcSEcCtD
Paclitaxel—Skin disorder—Capecitabine—esophageal cancer	3.96e-05	0.000572	CcSEcCtD
Paclitaxel—Hyperhidrosis—Capecitabine—esophageal cancer	3.94e-05	0.00057	CcSEcCtD
Paclitaxel—Anorexia—Capecitabine—esophageal cancer	3.88e-05	0.000562	CcSEcCtD
Paclitaxel—Angiopathy—Methotrexate—esophageal cancer	3.87e-05	0.00056	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—esophageal cancer	3.86e-05	0.000558	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—esophageal cancer	3.85e-05	0.000556	CcSEcCtD
Paclitaxel—Chills—Methotrexate—esophageal cancer	3.83e-05	0.000554	CcSEcCtD
Paclitaxel—Hypotension—Capecitabine—esophageal cancer	3.81e-05	0.000551	CcSEcCtD
Paclitaxel—Diarrhoea—Cisplatin—esophageal cancer	3.78e-05	0.000547	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—esophageal cancer	3.77e-05	0.000546	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—esophageal cancer	3.74e-05	0.000541	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—esophageal cancer	3.72e-05	0.000537	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—esophageal cancer	3.72e-05	0.000537	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Capecitabine—esophageal cancer	3.71e-05	0.000537	CcSEcCtD
Paclitaxel—Insomnia—Capecitabine—esophageal cancer	3.68e-05	0.000533	CcSEcCtD
Paclitaxel—Paraesthesia—Capecitabine—esophageal cancer	3.66e-05	0.000529	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—esophageal cancer	3.64e-05	0.000526	CcSEcCtD
Paclitaxel—Dyspnoea—Capecitabine—esophageal cancer	3.63e-05	0.000525	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—esophageal cancer	3.59e-05	0.00052	CcSEcCtD
Paclitaxel—Dyspepsia—Capecitabine—esophageal cancer	3.59e-05	0.000519	CcSEcCtD
Paclitaxel—Decreased appetite—Capecitabine—esophageal cancer	3.54e-05	0.000512	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Capecitabine—esophageal cancer	3.52e-05	0.000509	CcSEcCtD
Paclitaxel—Vomiting—Cisplatin—esophageal cancer	3.51e-05	0.000508	CcSEcCtD
Paclitaxel—Fatigue—Capecitabine—esophageal cancer	3.51e-05	0.000508	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—esophageal cancer	3.5e-05	0.000507	CcSEcCtD
Paclitaxel—Rash—Cisplatin—esophageal cancer	3.48e-05	0.000504	CcSEcCtD
Paclitaxel—Constipation—Capecitabine—esophageal cancer	3.48e-05	0.000504	CcSEcCtD
Paclitaxel—Pain—Capecitabine—esophageal cancer	3.48e-05	0.000504	CcSEcCtD
Paclitaxel—Dermatitis—Cisplatin—esophageal cancer	3.48e-05	0.000504	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—esophageal cancer	3.45e-05	0.000499	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—esophageal cancer	3.43e-05	0.000497	CcSEcCtD
Paclitaxel—Feeling abnormal—Capecitabine—esophageal cancer	3.36e-05	0.000486	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—esophageal cancer	3.35e-05	0.000485	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—esophageal cancer	3.34e-05	0.000483	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Capecitabine—esophageal cancer	3.33e-05	0.000482	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—esophageal cancer	3.33e-05	0.000481	CcSEcCtD
Paclitaxel—Nausea—Cisplatin—esophageal cancer	3.28e-05	0.000475	CcSEcCtD
Paclitaxel—Cough—Methotrexate—esophageal cancer	3.24e-05	0.000469	CcSEcCtD
Paclitaxel—Urticaria—Capecitabine—esophageal cancer	3.24e-05	0.000468	CcSEcCtD
Paclitaxel—Body temperature increased—Capecitabine—esophageal cancer	3.22e-05	0.000466	CcSEcCtD
Paclitaxel—Abdominal pain—Capecitabine—esophageal cancer	3.22e-05	0.000466	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—esophageal cancer	3.22e-05	0.000466	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—esophageal cancer	3.16e-05	0.000458	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—esophageal cancer	3.16e-05	0.000458	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—esophageal cancer	3.16e-05	0.000458	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	3.14e-05	0.000454	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—esophageal cancer	3.13e-05	0.000452	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—esophageal cancer	3.06e-05	0.000442	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—esophageal cancer	3.03e-05	0.000439	CcSEcCtD
Paclitaxel—Infection—Methotrexate—esophageal cancer	3.01e-05	0.000436	CcSEcCtD
Paclitaxel—Hypersensitivity—Capecitabine—esophageal cancer	3e-05	0.000434	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—esophageal cancer	2.97e-05	0.00043	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—esophageal cancer	2.97e-05	0.000429	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—esophageal cancer	2.95e-05	0.000426	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—esophageal cancer	2.93e-05	0.000424	CcSEcCtD
Paclitaxel—Asthenia—Capecitabine—esophageal cancer	2.92e-05	0.000423	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—esophageal cancer	2.89e-05	0.000418	CcSEcCtD
Paclitaxel—Pruritus—Capecitabine—esophageal cancer	2.88e-05	0.000417	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—esophageal cancer	2.83e-05	0.00041	CcSEcCtD
Paclitaxel—Diarrhoea—Capecitabine—esophageal cancer	2.79e-05	0.000403	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—esophageal cancer	2.76e-05	0.0004	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—esophageal cancer	2.74e-05	0.000397	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—esophageal cancer	2.72e-05	0.000394	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—esophageal cancer	2.7e-05	0.000391	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—esophageal cancer	2.7e-05	0.00039	CcSEcCtD
Paclitaxel—Dizziness—Capecitabine—esophageal cancer	2.69e-05	0.00039	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—esophageal cancer	2.67e-05	0.000386	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—esophageal cancer	2.64e-05	0.000381	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—esophageal cancer	2.62e-05	0.000379	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—esophageal cancer	2.61e-05	0.000378	CcSEcCtD
Paclitaxel—Pain—Methotrexate—esophageal cancer	2.59e-05	0.000375	CcSEcCtD
Paclitaxel—Vomiting—Capecitabine—esophageal cancer	2.59e-05	0.000375	CcSEcCtD
Paclitaxel—Rash—Capecitabine—esophageal cancer	2.57e-05	0.000372	CcSEcCtD
Paclitaxel—Dermatitis—Capecitabine—esophageal cancer	2.57e-05	0.000371	CcSEcCtD
Paclitaxel—Headache—Capecitabine—esophageal cancer	2.55e-05	0.000369	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—esophageal cancer	2.5e-05	0.000361	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—esophageal cancer	2.48e-05	0.000359	CcSEcCtD
Paclitaxel—Nausea—Capecitabine—esophageal cancer	2.42e-05	0.00035	CcSEcCtD
Paclitaxel—Urticaria—Methotrexate—esophageal cancer	2.41e-05	0.000348	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—esophageal cancer	2.4e-05	0.000347	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—esophageal cancer	2.4e-05	0.000347	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—esophageal cancer	2.23e-05	0.000323	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—esophageal cancer	2.18e-05	0.000315	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—esophageal cancer	2.15e-05	0.00031	CcSEcCtD
Paclitaxel—Diarrhoea—Methotrexate—esophageal cancer	2.07e-05	0.0003	CcSEcCtD
Paclitaxel—Dizziness—Methotrexate—esophageal cancer	2.01e-05	0.00029	CcSEcCtD
Paclitaxel—Vomiting—Methotrexate—esophageal cancer	1.93e-05	0.000279	CcSEcCtD
Paclitaxel—Rash—Methotrexate—esophageal cancer	1.91e-05	0.000277	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—esophageal cancer	1.91e-05	0.000276	CcSEcCtD
Paclitaxel—Headache—Methotrexate—esophageal cancer	1.9e-05	0.000275	CcSEcCtD
Paclitaxel—Nausea—Methotrexate—esophageal cancer	1.8e-05	0.000261	CcSEcCtD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.54e-06	5.64e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFBR2—esophageal cancer	3.53e-06	5.62e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ENO1—esophageal cancer	3.51e-06	5.6e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS1—esophageal cancer	3.51e-06	5.6e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.51e-06	5.6e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS1—esophageal cancer	3.48e-06	5.55e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ENO1—esophageal cancer	3.48e-06	5.55e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ADH1B—esophageal cancer	3.47e-06	5.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CA2—esophageal cancer	3.47e-06	5.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TPI1—esophageal cancer	3.46e-06	5.52e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTO1—esophageal cancer	3.46e-06	5.52e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PSME1—esophageal cancer	3.46e-06	5.52e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PSME2—esophageal cancer	3.46e-06	5.52e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.45e-06	5.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PLCE1—esophageal cancer	3.45e-06	5.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ADH7—esophageal cancer	3.45e-06	5.5e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.44e-06	5.48e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PSME2—esophageal cancer	3.43e-06	5.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PSME1—esophageal cancer	3.43e-06	5.47e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.42e-06	5.45e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP1B1—esophageal cancer	3.41e-06	5.44e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP1B1—esophageal cancer	3.39e-06	5.41e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.39e-06	5.4e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SMAD4—esophageal cancer	3.34e-06	5.32e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PIK3CA—esophageal cancer	3.33e-06	5.31e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.32e-06	5.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALDOB—esophageal cancer	3.32e-06	5.3e-05	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—esophageal cancer	3.32e-06	5.29e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TYMP—esophageal cancer	3.32e-06	5.29e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.26e-06	5.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP26A1—esophageal cancer	3.23e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERBB2—esophageal cancer	3.23e-06	5.14e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ADH7—esophageal cancer	3.22e-06	5.14e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.22e-06	5.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GAPDH—esophageal cancer	3.2e-06	5.1e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP19A1—esophageal cancer	3.19e-06	5.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.19e-06	5.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CRABP1—esophageal cancer	3.17e-06	5.05e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALOX15—esophageal cancer	3.15e-06	5.01e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP19A1—esophageal cancer	3.09e-06	4.92e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ADH1B—esophageal cancer	3.02e-06	4.82e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNG7—esophageal cancer	3.01e-06	4.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TPI1—esophageal cancer	3e-06	4.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTO1—esophageal cancer	3e-06	4.78e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.99e-06	4.77e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP1B1—esophageal cancer	2.99e-06	4.76e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP1B1—esophageal cancer	2.96e-06	4.72e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.96e-06	4.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.94e-06	4.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.94e-06	4.69e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—HMOX1—esophageal cancer	2.93e-06	4.66e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—HMOX1—esophageal cancer	2.91e-06	4.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TYMP—esophageal cancer	2.89e-06	4.61e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.88e-06	4.59e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.87e-06	4.58e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.86e-06	4.56e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.84e-06	4.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.83e-06	4.5e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALDH2—esophageal cancer	2.82e-06	4.5e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—HMOX1—esophageal cancer	2.82e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.81e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.81e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP19A1—esophageal cancer	2.81e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ABCB1—esophageal cancer	2.81e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ABCB1—esophageal cancer	2.8e-06	4.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP19A1—esophageal cancer	2.78e-06	4.44e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.77e-06	4.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.77e-06	4.41e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.76e-06	4.41e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDKN1A—esophageal cancer	2.76e-06	4.4e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.74e-06	4.38e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALOX15—esophageal cancer	2.74e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HIF1A—esophageal cancer	2.73e-06	4.35e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ABCB1—esophageal cancer	2.7e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TYMP—esophageal cancer	2.7e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTT1—esophageal cancer	2.69e-06	4.28e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP2A6—esophageal cancer	2.66e-06	4.23e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CREBBP—esophageal cancer	2.64e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.63e-06	4.19e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EP300—esophageal cancer	2.62e-06	4.18e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TPI1—esophageal cancer	2.61e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTO1—esophageal cancer	2.61e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNG7—esophageal cancer	2.61e-06	4.16e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—HMOX1—esophageal cancer	2.56e-06	4.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.56e-06	4.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—HMOX1—esophageal cancer	2.54e-06	4.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ENO1—esophageal cancer	2.52e-06	4.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.52e-06	4.01e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALDOB—esophageal cancer	2.51e-06	4e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.5e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA1—esophageal cancer	2.5e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CREBBP—esophageal cancer	2.49e-06	3.97e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOS2—esophageal cancer	2.48e-06	3.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PSME2—esophageal cancer	2.48e-06	3.95e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PSME1—esophageal cancer	2.48e-06	3.95e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOTCH1—esophageal cancer	2.46e-06	3.92e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ABCB1—esophageal cancer	2.46e-06	3.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.45e-06	3.9e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TPI1—esophageal cancer	2.44e-06	3.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.44e-06	3.89e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ABCB1—esophageal cancer	2.44e-06	3.89e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GAPDH—esophageal cancer	2.41e-06	3.85e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.41e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CRABP1—esophageal cancer	2.39e-06	3.81e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—NOS3—esophageal cancer	2.37e-06	3.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.34e-06	3.73e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.33e-06	3.71e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.33e-06	3.71e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.3e-06	3.67e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.29e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA2—esophageal cancer	2.29e-06	3.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNG7—esophageal cancer	2.27e-06	3.63e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.25e-06	3.59e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—esophageal cancer	2.24e-06	3.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.23e-06	3.56e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CREBBP—esophageal cancer	2.23e-06	3.56e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—NOS3—esophageal cancer	2.23e-06	3.55e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.18e-06	3.48e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ENO1—esophageal cancer	2.18e-06	3.48e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—esophageal cancer	2.16e-06	3.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PSME1—esophageal cancer	2.15e-06	3.43e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PSME2—esophageal cancer	2.15e-06	3.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.14e-06	3.41e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALDH2—esophageal cancer	2.13e-06	3.4e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ADH7—esophageal cancer	2.13e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.13e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNG7—esophageal cancer	2.12e-06	3.39e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.12e-06	3.38e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.11e-06	3.37e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.04e-06	3.26e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—esophageal cancer	2.04e-06	3.25e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTT1—esophageal cancer	2.03e-06	3.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.01e-06	3.21e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP2A6—esophageal cancer	2e-06	3.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOS3—esophageal cancer	2e-06	3.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.99e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—esophageal cancer	1.94e-06	3.09e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS1—esophageal cancer	1.9e-06	3.03e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO1—esophageal cancer	1.9e-06	3.03e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.9e-06	3.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.89e-06	3.02e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.88e-06	2.99e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.88e-06	2.99e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.87e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PSME2—esophageal cancer	1.87e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PSME1—esophageal cancer	1.87e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CREBBP—esophageal cancer	1.87e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—esophageal cancer	1.87e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.86e-06	2.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.86e-06	2.97e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.85e-06	2.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.84e-06	2.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—esophageal cancer	1.83e-06	2.91e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CREBBP—esophageal cancer	1.81e-06	2.88e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—EP300—esophageal cancer	1.8e-06	2.87e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TYMP—esophageal cancer	1.78e-06	2.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.77e-06	2.83e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO1—esophageal cancer	1.77e-06	2.83e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.76e-06	2.81e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PSME1—esophageal cancer	1.75e-06	2.79e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PSME2—esophageal cancer	1.75e-06	2.79e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.74e-06	2.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.73e-06	2.76e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—EP300—esophageal cancer	1.69e-06	2.7e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.69e-06	2.69e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NOS3—esophageal cancer	1.68e-06	2.68e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NOS3—esophageal cancer	1.67e-06	2.67e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CREBBP—esophageal cancer	1.64e-06	2.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.63e-06	2.6e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NOS3—esophageal cancer	1.62e-06	2.58e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.61e-06	2.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TPI1—esophageal cancer	1.61e-06	2.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.61e-06	2.57e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1A—esophageal cancer	1.6e-06	2.55e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.59e-06	2.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.56e-06	2.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.54e-06	2.46e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—esophageal cancer	1.54e-06	2.45e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—esophageal cancer	1.53e-06	2.44e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.53e-06	2.43e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.53e-06	2.43e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EP300—esophageal cancer	1.52e-06	2.42e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.52e-06	2.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.51e-06	2.41e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.49e-06	2.37e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—esophageal cancer	1.48e-06	2.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.47e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NOS3—esophageal cancer	1.47e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NOS3—esophageal cancer	1.46e-06	2.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.42e-06	2.26e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNG7—esophageal cancer	1.4e-06	2.23e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HMOX1—esophageal cancer	1.39e-06	2.21e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—esophageal cancer	1.35e-06	2.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—esophageal cancer	1.33e-06	2.13e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	1.33e-06	2.12e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—esophageal cancer	1.32e-06	2.11e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.31e-06	2.09e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—esophageal cancer	1.3e-06	2.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.29e-06	2.06e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—EP300—esophageal cancer	1.28e-06	2.04e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—EP300—esophageal cancer	1.27e-06	2.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.27e-06	2.02e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—esophageal cancer	1.25e-06	2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.25e-06	1.99e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.24e-06	1.98e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.23e-06	1.97e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—EP300—esophageal cancer	1.23e-06	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.18e-06	1.88e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO1—esophageal cancer	1.17e-06	1.87e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.17e-06	1.87e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.15e-06	1.84e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PSME1—esophageal cancer	1.15e-06	1.84e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PSME2—esophageal cancer	1.15e-06	1.84e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—esophageal cancer	1.12e-06	1.79e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—EP300—esophageal cancer	1.12e-06	1.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—EP300—esophageal cancer	1.11e-06	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NOS3—esophageal cancer	1.05e-06	1.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.02e-06	1.63e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.95e-07	1.59e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—esophageal cancer	9.65e-07	1.54e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—esophageal cancer	9.45e-07	1.51e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—esophageal cancer	9.41e-07	1.5e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.39e-07	1.5e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.35e-07	1.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NOS3—esophageal cancer	9.13e-07	1.46e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—esophageal cancer	9.1e-07	1.45e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CREBBP—esophageal cancer	8.89e-07	1.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.54e-07	1.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—esophageal cancer	8.35e-07	1.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CREBBP—esophageal cancer	8.3e-07	1.32e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—esophageal cancer	8.28e-07	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—esophageal cancer	8.21e-07	1.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.19e-07	1.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—EP300—esophageal cancer	8.02e-07	1.28e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NOS3—esophageal cancer	7.96e-07	1.27e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NOS3—esophageal cancer	7.43e-07	1.19e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—esophageal cancer	7.28e-07	1.16e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—EP300—esophageal cancer	6.95e-07	1.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.8e-07	1.08e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—EP300—esophageal cancer	6.05e-07	9.65e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—esophageal cancer	5.93e-07	9.46e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—EP300—esophageal cancer	5.66e-07	9.02e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.48e-07	8.73e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—esophageal cancer	5.14e-07	8.19e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NOS3—esophageal cancer	4.9e-07	7.82e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.48e-07	7.15e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.48e-07	7.14e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4.18e-07	6.67e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—EP300—esophageal cancer	3.73e-07	5.95e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.76e-07	4.4e-06	CbGpPWpGaD
